Literature DB >> 10590147

Plasmid-driven formation of influenza virus-like particles.

G Neumann1, T Watanabe, Y Kawaoka.   

Abstract

We established a plasmid-based system for generating infectious influenza virus-like particles entirely from cloned cDNAs. Human embryonic kidney cells (293T) were transfected with plasmids encoding the influenza A virus structural proteins and with a plasmid encoding an influenza virus-like viral RNA (vRNA) which contained an antisense copy of the cDNA for green fluorescence protein (GFP) flanked by an RNA polymerase I promoter and terminator. Intracellular transcription of the latter construct by RNA polymerase I generated GFP vRNA that was packaged into influenza virus-like particles. This system, which produced more than 10(4) infectious particles per ml of supernatant, would be useful in studies of influenza virus replication and particle formation. It might also benefit efforts in vaccine production and in the development of improved gene therapy vectors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10590147      PMCID: PMC111569          DOI: 10.1128/jvi.74.1.547-551.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Mutational analysis of influenza virus promoter elements in vivo.

Authors:  G Neumann; G Hobom
Journal:  J Gen Virol       Date:  1995-07       Impact factor: 3.891

2.  The cytoplasmic tail of the neuraminidase protein of influenza A virus does not play an important role in the packaging of this protein into viral envelopes.

Authors:  A García-Sastre; P Palese
Journal:  Virus Res       Date:  1995-06       Impact factor: 3.303

3.  Rescue of a synthetic chloramphenicol acetyltransferase RNA into influenza virus-like particles obtained from recombinant plasmids.

Authors:  I Mena; A Vivo; E Pérez; A Portela
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Generation of influenza A viruses entirely from cloned cDNAs.

Authors:  G Neumann; T Watanabe; H Ito; S Watanabe; H Goto; P Gao; M Hughes; D R Perez; R Donis; E Hoffmann; G Hobom; Y Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

5.  RNA polymerase of influenza virus: role of NP in RNA chain elongation.

Authors:  A Honda; K Uéda; K Nagata; A Ishihama
Journal:  J Biochem       Date:  1988-12       Impact factor: 3.387

6.  Basis for selective incorporation of glycoproteins into the influenza virus envelope.

Authors:  H Y Naim; M G Roth
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

7.  The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication.

Authors:  L J Mitnaul; M R Castrucci; K G Murti; Y Kawaoka
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA.

Authors:  M M Rolls; P Webster; N H Balba; J K Rose
Journal:  Cell       Date:  1994-11-04       Impact factor: 41.582

9.  RNA polymerase I-mediated expression of influenza viral RNA molecules.

Authors:  G Neumann; A Zobel; G Hobom
Journal:  Virology       Date:  1994-07       Impact factor: 3.616

10.  The influenza virus hemagglutinin cytoplasmic tail is not essential for virus assembly or infectivity.

Authors:  H Jin; G P Leser; R A Lamb
Journal:  EMBO J       Date:  1994-11-15       Impact factor: 11.598

View more
  42 in total

1.  Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.

Authors:  J T Voeten; T M Bestebroer; N J Nieuwkoop; R A Fouchier; A D Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Reverse genetics system for Uukuniemi virus (Bunyaviridae): RNA polymerase I-catalyzed expression of chimeric viral RNAs.

Authors:  R Flick; R F Pettersson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 3.  Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.

Authors:  Gavin C Bowick; Alexander J McAuley
Journal:  Bioeng Bugs       Date:  2011-05-01

4.  Defective assembly of influenza A virus due to a mutation in the polymerase subunit PA.

Authors:  John F Regan; Yuying Liang; Tristram G Parslow
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication.

Authors:  Makoto Ozawa; Ken Fujii; Yukiko Muramoto; Shinya Yamada; Seiya Yamayoshi; Ayato Takada; Hideo Goto; Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

6.  Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions.

Authors:  Yukiko Muramoto; Ayato Takada; Ken Fujii; Takeshi Noda; Kiyoko Iwatsuki-Horimoto; Shinji Watanabe; Taisuke Horimoto; Hiroshi Kida; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

7.  An adenovirus vector-mediated reverse genetics system for influenza A virus generation.

Authors:  Makoto Ozawa; Hideo Goto; Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

8.  Display of heterologous proteins on gp64null baculovirus virions and enhanced budding mediated by a vesicular stomatitis virus G-stem construct.

Authors:  Jian Zhou; Gary W Blissard
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

9.  Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles.

Authors:  Benjamin J Chen; George P Leser; Eiji Morita; Robert A Lamb
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

10.  Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge.

Authors:  Zhiyuan Wen; Ling Ye; Yulong Gao; Lei Pan; Ke Dong; Zhigao Bu; Richard W Compans; Chinglai Yang
Journal:  Antiviral Res       Date:  2009-09-20       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.